430 related articles for article (PubMed ID: 16460010)
1. Analysis of ligand binding and protein dynamics of human retinoid X receptor alpha ligand-binding domain by nuclear magnetic resonance.
Lu J; Cistola DP; Li E
Biochemistry; 2006 Feb; 45(6):1629-39. PubMed ID: 16460010
[TBL] [Abstract][Full Text] [Related]
2. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
3. Effect of heterodimer partner RXRalpha on PPARgamma activation function-2 helix in solution.
Lu J; Chen M; Stanley SE; Li E
Biochem Biophys Res Commun; 2008 Jan; 365(1):42-6. PubMed ID: 17980149
[TBL] [Abstract][Full Text] [Related]
4. Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.
Xia G; Boerma LJ; Cox BD; Qiu C; Kang S; Smith CD; Renfrow MB; Muccio DD
Biochemistry; 2011 Jan; 50(1):93-105. PubMed ID: 21049972
[TBL] [Abstract][Full Text] [Related]
5. The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain.
Lu J; Dawson MI; Hu QY; Xia Z; Dambacher JD; Ye M; Zhang XK; Li E
Magn Reson Chem; 2009 Dec; 47(12):1071-80. PubMed ID: 19757405
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry.
Yan X; Broderick D; Leid ME; Schimerlik MI; Deinzer ML
Biochemistry; 2004 Feb; 43(4):909-17. PubMed ID: 14744134
[TBL] [Abstract][Full Text] [Related]
7. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid.
Egea PF; Mitschler A; Rochel N; Ruff M; Chambon P; Moras D
EMBO J; 2000 Jun; 19(11):2592-601. PubMed ID: 10835357
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of allosteric communication in the human PPARalpha-RXRalpha heterodimer.
Venäläinen T; Molnár F; Oostenbrink C; Carlberg C; Peräkylä M
Proteins; 2010 Mar; 78(4):873-87. PubMed ID: 19847917
[TBL] [Abstract][Full Text] [Related]
10. The RXRalpha C-terminus T462 is a NMR sensor for coactivator peptide binding.
Lu J; Chen M; Dekoster GT; Cistola DP; Li E
Biochem Biophys Res Commun; 2008 Feb; 366(4):932-7. PubMed ID: 18088598
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor.
de Groot A; de Rosny E; Juillan-Binard C; Ferrer JL; Laudet V; Pierce RJ; Pebay-Peyroula E; Fontecilla-Camps JC; Borel F
J Mol Biol; 2005 Dec; 354(4):841-53. PubMed ID: 16274693
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
13. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
14. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha.
Bogan AA; Dallas-Yang Q; Ruse MD; Maeda Y; Jiang G; Nepomuceno L; Scanlan TS; Cohen FE; Sladek FM
J Mol Biol; 2000 Sep; 302(4):831-51. PubMed ID: 10993727
[TBL] [Abstract][Full Text] [Related]
15. A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor α.
Eberhardt J; McEwen AG; Bourguet W; Moras D; Dejaegere A
Acta Crystallogr F Struct Biol Commun; 2019 Feb; 75(Pt 2):98-104. PubMed ID: 30713160
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix.
Gampe RT; Montana VG; Lambert MH; Wisely GB; Milburn MV; Xu HE
Genes Dev; 2000 Sep; 14(17):2229-41. PubMed ID: 10970886
[TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of type II human cellular retinoic acid binding protein: implications for ligand binding.
Wang L; Li Y; Abildgaard F; Markley JL; Yan H
Biochemistry; 1998 Sep; 37(37):12727-36. PubMed ID: 9737849
[TBL] [Abstract][Full Text] [Related]
18. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.
Suino K; Peng L; Reynolds R; Li Y; Cha JY; Repa JJ; Kliewer SA; Xu HE
Mol Cell; 2004 Dec; 16(6):893-905. PubMed ID: 15610733
[TBL] [Abstract][Full Text] [Related]
19. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.
Gampe RT; Montana VG; Lambert MH; Miller AB; Bledsoe RK; Milburn MV; Kliewer SA; Willson TM; Xu HE
Mol Cell; 2000 Mar; 5(3):545-55. PubMed ID: 10882139
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.
Wang N; Zou Q; Xu J; Zhang J; Liu J
J Biol Chem; 2018 Nov; 293(47):18180-18191. PubMed ID: 30275017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
